Dr Janet Bastiman discusses the future of AI for AML and offers expert guidance on how best to collaborate with the FCA and ...

According to a TRM Labs report, illicit flows reached about $154–158 billion in 2025, and regulators increased pressure ...

An announcement from Aptose Biosciences ( (TSE:APS)) is now available. Aptose Biosciences Inc., a clinical-stage biotech developer of precision oncology drugs focused on hematologic malignancies, is ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

The latest update keeps Dye & Durham’s central fair value at CA$5.00, while analyst price targets remain tightly grouped between CA$4 and CA$5. That split reflects a careful balance between cautious ...

Abizer Diwanji, Founder of NeoStrat Advisors LLP, and Sachin Dixit, Lead Internet Research Analyst at JM Financial ...

April 29 (Reuters) - British luxury carmaker Aston Martin on Wednesday reported a narrower first-quarter, loss helped by ...

The firms AMLA will supervise directly are the firms most exposed to the jurisdictional complexity that makes contextual ...

AI doesn't think — it calculates. A blockchain dev explains why blind trust in chatbots erodes critical thinking and invites ...

SLS and ATNM are heading into the AACR summit with fresh leukemia-focused data catalysts expected to refocus investor attention. ・Sellas will present preclinical AML data on SLS009, demonstrating ...

The update helps financial institutions better identify their customers, understand where money is coming from, track unusual trade activity ...